DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Australia
  • /
  • Healthcare
Author Program NEWCreate Narrative
SIG logo

Sigma Healthcare Limited Stock Price

ASX:SIG Community·AU$30.4b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 55 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

SIG Share Price Performance

AU$2.64
-0.36 (-12.00%)
​
AU$2.60
Fair Value
AU$2.64
-0.36 (-12.00%)
1.5% overvalued intrinsic discount
AU$2.60
Fair Value
Price AU$2.64
AnalystLowTarget AU$2.60
AnalystConsensusTarget AU$3.20
Thu, 27 Aug 26
Fair ValueAU$2.60
Share Pricen/a

SIG Community Narratives

AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value AU$2.6 1.5% overvalued intrinsic discount

GLP-1 Demand And Store Expansion Will Shape Margins And Earnings Trajectory

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value AU$3.2 17.5% undervalued intrinsic discount

Aging Population And Store Expansion Will Support Long Term Pharmacy Earnings Resilience

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
SIG logo
Sigma Healthcare
1.5% overvalued intrinsic discount

GLP-1 Demand And Store Expansion Will Shape Margins And Earnings Trajectory

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Published 27 Aug
Read Narrative
SIG logo
Sigma Healthcare
17.5% undervalued intrinsic discount
New

Aging Population And Store Expansion Will Support Long Term Pharmacy Earnings Resilience

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Published 10 Sep
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
SIG logo

Aging Population And Store Expansion Will Support Long Term Pharmacy Earnings Resilience

Fair Value: AU$3.2 17.5% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
SIG logo

GLP-1 Demand And Store Expansion Will Shape Margins And Earnings Trajectory

Fair Value: AU$2.6 1.5% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet and good value.

0 Risks
4 Rewards
View Full Analysis

Sigma Healthcare Limited Key Details

AU$10.8b

Revenue

AU$8.9b

Cost of Revenue

AU$2.0b

Gross Profit

AU$1.2b

Other Expenses

AU$709.2m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.062
18.06%
6.55%
15.9%
View Full Analysis

About SIG

Founded
1912
Employees
n/a
CEO
Vikesh Ramsunder
WebsiteView website
sigmahealthcare.com.au

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.

Recent SIG News & Updates

User avatar
New Narrative • Sep 10

Aging Population And Store Expansion Will Support Long Term Pharmacy Earnings Resilience

Catalysts About Sigma Healthcare Sigma Healthcare operates a large pharmacy franchise and wholesale distribution business focused on community health and medicines. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Aug 27

GLP-1 Demand And Store Expansion Will Shape Margins And Earnings Trajectory

Catalysts About Sigma Healthcare Sigma Healthcare operates a pharmacy wholesale, distribution and franchise network across Australia and selected international markets, including Chemist Warehouse, Amcal and Discount Drug Stores. What are the underlying business or industry changes driving this perspective?

Recent updates

No updates

Sigma Healthcare Limited Competitors

PME logo

Pro Medicus

Symbol: ASX:PME
Market cap: AU$17.4b
RHC logo

Ramsay Health Care

Symbol: ASX:RHC
Market cap: AU$12.4b
SHL logo

Sonic Healthcare

Symbol: ASX:SHL
Market cap: AU$9.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide